tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market
CRNX
Crinetics Pharmaceuticals
RESEARCH TOOLSreports

Crinetics Pharmaceuticals (CRNX) Income Statement

766 Followers

Crinetics Pharmaceuticals Income Statement

Last quarter (Q4 2025), Crinetics Pharmaceuticals's total revenue was $3.88M, an increase of Infinity% from the same quarter last year. In Q4, Crinetics Pharmaceuticals's net income was $-122.81M. See Crinetics Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.70M$ 1.04M$ 4.01M$ 4.74M$ 1.08M
Gross Profit
$ 2.73M$ 1.04M$ 4.01M$ 4.74M$ 1.08M
Operating Expenses
$ 519.50M$ 339.89M$ 226.62M$ 172.62M$ 108.78M
Depreciation and Amortization
$ 3.89M$ 2.79M$ 1.10M$ 983.00K$ 922.00K
EBITDA
$ -461.25M$ -336.07M$ -221.51M$ -166.90M$ -106.78M
Operating Income
$ -516.77M$ -338.85M$ -222.61M$ -167.88M$ -107.70M
Other Income/Expenses
$ 51.63M$ 40.45M$ 8.08M$ 3.96M$ 61.00K
Pretax Income
$ -465.14M$ -298.41M$ -214.53M$ -163.92M$ -107.64M
Net Income
$ -465.32M$ -298.41M$ -214.53M$ -163.92M$ -107.64M
Per Share Metrics
Basic EPS
$ -4.95$ -3.69$ -3.69$ -3.15$ -2.80
Diluted EPS
$ -4.95$ -3.69$ -3.69$ -3.15$ -2.80
Weighted Average Shares Outstanding
 94.06M 80.78M 58.07M 51.98M 38.44M
Weighted Average Shares Outstanding (Diluted)
 94.06M 80.78M 58.07M 51.98M 38.44M
Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History